Cargando…

Analysis of the quality of life of patients with asthma and allergic rhinitis after immunotherapy

AIM: To assess the quality of life of Polish patients with asthma and/or allergic rhinitis before the implementation and after 30–36 months of immunotherapy. MATERIAL AND METHODS: Two hundred patients have been involved in the study: 101 with allergic asthma and 99 with pollinosis. In order to colle...

Descripción completa

Detalles Bibliográficos
Autores principales: Filanowicz, Małgorzata, Szynkiewicz, Ewa, Cegła, Bernadeta, Bartuzi, Zbigniew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884771/
https://www.ncbi.nlm.nih.gov/pubmed/27279823
http://dx.doi.org/10.5114/pdia.2015.48061
_version_ 1782434411395940352
author Filanowicz, Małgorzata
Szynkiewicz, Ewa
Cegła, Bernadeta
Bartuzi, Zbigniew
author_facet Filanowicz, Małgorzata
Szynkiewicz, Ewa
Cegła, Bernadeta
Bartuzi, Zbigniew
author_sort Filanowicz, Małgorzata
collection PubMed
description AIM: To assess the quality of life of Polish patients with asthma and/or allergic rhinitis before the implementation and after 30–36 months of immunotherapy. MATERIAL AND METHODS: Two hundred patients have been involved in the study: 101 with allergic asthma and 99 with pollinosis. In order to collect research material, the Polish versions of AQLQ (Asthma Quality of Life) and RQLQ (Rhinoconjunctivitis Quality of Life) questionnaires have been used. The self-administered questionnaires concerned such data as age, sex and the patients’ subjective evaluation of their quality of life. RESULTS: The average increase in quality of life of patients with asthma was 0.84 and of patients with allergic rhinitis – 1.50. A hypothesis was made that changes of quality of life in each examined group differed significantly. A test for two fractions showed that for patients with asthma it was 7.74 and for patients with allergic rhinitis – 10.38. A statistical analysis showed no such relation in the group of patients with asthma (coefficient of correlation = 0.08) and a slight correlation in the group of patients with allergic rhinitis (coefficient of correlation = 0.20). Applied tests did not show any significant differences, which means that an average increase in quality of life does not depend on sex and age of both examined groups. CONCLUSIONS: On the basis of the research conducted among patients before and after a 3-year period of immunotherapy, the following conclusions have been drawn: 1) immunotherapy significantly improves the objective quality of life in both groups; 2) a slight correlation has been identified between the objective and subjective dimension of quality of life amongst patients with asthma, what contributes to a better quality of life; 3) in both study groups, no significant relationship between gender or age and improvement in quality of life has been noted; 4) immunotherapy, from the point of view of the improvement of quality of life, is a valuable therapeutic tool in patients with atopic bronchial asthma and allergic rhinitis.
format Online
Article
Text
id pubmed-4884771
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-48847712016-06-08 Analysis of the quality of life of patients with asthma and allergic rhinitis after immunotherapy Filanowicz, Małgorzata Szynkiewicz, Ewa Cegła, Bernadeta Bartuzi, Zbigniew Postepy Dermatol Alergol Original Paper AIM: To assess the quality of life of Polish patients with asthma and/or allergic rhinitis before the implementation and after 30–36 months of immunotherapy. MATERIAL AND METHODS: Two hundred patients have been involved in the study: 101 with allergic asthma and 99 with pollinosis. In order to collect research material, the Polish versions of AQLQ (Asthma Quality of Life) and RQLQ (Rhinoconjunctivitis Quality of Life) questionnaires have been used. The self-administered questionnaires concerned such data as age, sex and the patients’ subjective evaluation of their quality of life. RESULTS: The average increase in quality of life of patients with asthma was 0.84 and of patients with allergic rhinitis – 1.50. A hypothesis was made that changes of quality of life in each examined group differed significantly. A test for two fractions showed that for patients with asthma it was 7.74 and for patients with allergic rhinitis – 10.38. A statistical analysis showed no such relation in the group of patients with asthma (coefficient of correlation = 0.08) and a slight correlation in the group of patients with allergic rhinitis (coefficient of correlation = 0.20). Applied tests did not show any significant differences, which means that an average increase in quality of life does not depend on sex and age of both examined groups. CONCLUSIONS: On the basis of the research conducted among patients before and after a 3-year period of immunotherapy, the following conclusions have been drawn: 1) immunotherapy significantly improves the objective quality of life in both groups; 2) a slight correlation has been identified between the objective and subjective dimension of quality of life amongst patients with asthma, what contributes to a better quality of life; 3) in both study groups, no significant relationship between gender or age and improvement in quality of life has been noted; 4) immunotherapy, from the point of view of the improvement of quality of life, is a valuable therapeutic tool in patients with atopic bronchial asthma and allergic rhinitis. Termedia Publishing House 2016-05-16 2016-04 /pmc/articles/PMC4884771/ /pubmed/27279823 http://dx.doi.org/10.5114/pdia.2015.48061 Text en Copyright © 2016 Termedia Sp. z o.o http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Filanowicz, Małgorzata
Szynkiewicz, Ewa
Cegła, Bernadeta
Bartuzi, Zbigniew
Analysis of the quality of life of patients with asthma and allergic rhinitis after immunotherapy
title Analysis of the quality of life of patients with asthma and allergic rhinitis after immunotherapy
title_full Analysis of the quality of life of patients with asthma and allergic rhinitis after immunotherapy
title_fullStr Analysis of the quality of life of patients with asthma and allergic rhinitis after immunotherapy
title_full_unstemmed Analysis of the quality of life of patients with asthma and allergic rhinitis after immunotherapy
title_short Analysis of the quality of life of patients with asthma and allergic rhinitis after immunotherapy
title_sort analysis of the quality of life of patients with asthma and allergic rhinitis after immunotherapy
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884771/
https://www.ncbi.nlm.nih.gov/pubmed/27279823
http://dx.doi.org/10.5114/pdia.2015.48061
work_keys_str_mv AT filanowiczmałgorzata analysisofthequalityoflifeofpatientswithasthmaandallergicrhinitisafterimmunotherapy
AT szynkiewiczewa analysisofthequalityoflifeofpatientswithasthmaandallergicrhinitisafterimmunotherapy
AT cegłabernadeta analysisofthequalityoflifeofpatientswithasthmaandallergicrhinitisafterimmunotherapy
AT bartuzizbigniew analysisofthequalityoflifeofpatientswithasthmaandallergicrhinitisafterimmunotherapy